The proliferative status of thyrotropes is dependent on modulation of specific cell cycle regulators by thyroid hormone

Endocrinology

Volumn 147, Issue 1, 2006, Pages 272-282

  Woodmansee, Whitney W ^a   Kerr, Janice M ^a   Tucker, Elizabeth A ^a   Mitchell, Jeffrey R ^a   Haakinson, Danielle J ^a   Gordon, David F ^a   Ridgway, E Chester ^a   Wood, William M ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b Division of Endocrinology Metabolism and Diabetes   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN A; CYCLIN B; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; GROWTH INHIBITOR; ISOPROTEIN; LIOTHYRONINE; MITOGEN ACTIVATED PROTEIN KINASE; RECEPTOR; RETINOBLASTOMA PROTEIN; SOMATOSTATIN; THYROID HORMONE; THYROXINE;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEPHOSPHORYLATION; DOSE RESPONSE; DOWN REGULATION; DRUG MECHANISM; DRUG WITHDRAWAL; ENZYME ACTIVATION; FLOW CYTOMETRY; HORMONE ACTION; HYPOPHYSIS CELL; HYPOPHYSIS TUMOR; IMMUNOHISTOCHEMISTRY; MITOSIS; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UPREGULATION;

ANIMALS; DISEASE MODELS, ANIMAL; HYPOTHYROIDISM; MICE; MICE, INBRED STRAINS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PROLIFERATING CELL NUCLEAR ANTIGEN; THYROID GLAND; THYROID HORMONES; THYROIDECTOMY; THYROTROPIN;

EID: 29344442842     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-1013     Document Type: Article

References (76)

1. Messier B 1966 Changes in the number of mouse thyrotropes following radiothyroidectomy. Acta Endocrinol (Copenh) 52:391-398
2. Surks MI, DeFesi CR 1977 Determination of the cell number of each cell type in the anterior pituitary of euthyroid and hypothyroid rats. Endocrinology 101:946-958
3. Marshall Jr MC, Williams D, Weintraub BD 1981 Regulation of de novo biosynthesis of thyrotropin in normal, hyperplastic, and neoplastic thyrotrophs. Endocrinology 108:908-915
4. Quintanar-Stephano A, Valverde C 1997 Mitogenic effects of thyroxine and TRH on thyrotrophs and somatotrophs of the anterior pituitary gland in thyroidectomized rats. J Endocrinol 154:149-153
5. Quintanar-Stephano A, Valverde R, Kovacs K 1999 Mitotic counts in rat adenohypophysial thyrotrophs and somatotrophs: effects of short-term thyroidectomy, thyroxine, and thyrotropin-releasing hormone. Endocr Pathol 10:335-341
6. Nolan LA, Thomas CK, Levy A 2004 Permissive effects of thyroid hormones on rat anterior pituitary mitotic activity. J Endocrinol 180:35-43
7. Malaguti A, Della CC, Castorina S, Martelli AM, Roti E, Martino E, Toni R 2004 Molecular mechanisms for pituitary thyrotroph cell growth. J Endocrinol Invest 27:151-167
8. Furth J 1955 Experimental pituitary tumors. Recent Prog Horm Res 11:221-257
9. Furth J, Moy P, Hershman JM, Ueda G 1973 Thyrotropic tumor syndrome. A multiglandular disease induced by sustained deficiency of thyroid hormones. Arch Pathol 96:217-226
10. Sarapura VD, Wood WM, Gordon DF, Ridgway EC 1993 Effect of thyroid hormone on T3-receptor mRNA levels and growth of thyrotropic tumors. Mol Cell Endocrinol 91:75-81
11. Sherr CJ 2000 The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 60:3689-3695
12. Sherr CJ 1994 Growth factor-regulated G1 cyclins. Stem Cells 12(Suppl 1):47-55
13. Lundberg AS, Weinberg RA 1998 Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclincdk complexes. Mol Cell Biol 18:753-761
14. Sherr CJ, Roberts JM 1995 Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163
15. Wood WM, Sarapura VD, Dowding JM, Woodmansee WW, Haakinson DJ, Gordon DF, Ridgway EC 2002 Early gene expression changes preceding thyroid hormone-induced involution of a thyrotrope tumor. Endocrinology 143:347-359
16. Ogino A, Yoshino A, Katayama Y, Watanabe T, Ota T, Komine C, Yokoyama T, Fukushima T 2005 The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas. J Neuropathol Exp Neurol 64:398-403
17. Frost SJ, Simpson DJ, Farrell WE 2001 Decreased proliferation and cell cycle arrest in neoplastic rat pituitary cells is associated with transforming growth factor-β1-induced expression of p15/INK4B. Mol Cell Endocrinol 176:29-37
18. Lamberts SW, Krenning EP, Reubi JC 1991 The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 12:450-482
19. Shimon I, Melmed S 1998 Management of pituitary tumors. Ann Intern Med 129:472-483
20. Chanson P, Weintraub BD, Harris AG 1993 Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients. Ann Intern Med 119:236-240
21. Patel YC 1999 Somatostatin and its receptor family. Front Neuroendocrinol 20:157-198
22. James R.A., Sarapura VD, Bruns C, Raulf F, Dowding JM, Gordon DF, Wood WM, Ridgway EC 1997 Thyroid hormone-induced expression of specific somatostatin receptor subtypes correlates with involution of the TtT-97 murine thyrotrope tumor. Endocrinology 138:719-724
23. Woodmansee WW, Gordon DF, Dowding JM, Stolz B, Lloyd RV, James RA, Wood WM, Ridgway EC 2000 The effect of thyroid hormone and a long-acting somatostatin analogue on TtT-97 murine thyrotropic tumors. Thyroid 10:533-541
24. Pierce KL, Luttrell LM, Lefkowitz RJ 2001 New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene 20:1532-1539
25. Tsukada Y, Miyazawa K, Kitamura N 2001 High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2. J Biol Chem 276:40968-40976
26. Tsukada Y, Tanaka T, Miyazawa K, Kitamura N 2004 Involvement of down-regulation of Cdk2 activity in hepatocyte growth factor-induced cell cycle arrest at G1 in the human hepatocellular carcinoma cell line HepG2. J Biochem (Tokyo) 136:701-709
27. Lahlou H, Saint-Laurent N, Esteve JP, Eychene A, Pradayrol L, Pyronnet S, Susini C 2003 sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation. J Biol Chem 278:39356-39371
28. Wood WM, Ocran KO, Gordon DF, Ridgway EC 1991 Isolation and characterization of mouse complementary DNAs encoding α and β thyroid hormone receptors from thyrotrope cells: the mouse pituitary specific β-2 isoform differs at the amino terminus from the corresponding species from rat pituitary tumor cells. Mol Endocrinol 5:1049-1061
29. Yusta B, Alarid ET, Gordon DF, Ridgway EC, Mellon PL 1998 The TSH β-subunit gene is repressed by thyroid hormone in a novel thyrotrope cell line, mouse TαT1 cells. Endocrinology 139:4476-4482
30. Shupnik MA, Chin WW, Habener JF, Ridgway EC 1985 Transcriptional regulation of the thyrotropin subunit genes by thyroid hormone. J Biol Chem 260:2900-2903
31. Nishimoto T, Uzawa S, Schlegel R 1992 Mitotic checkpoints. Curr Opin Cell Biol 4:174-179
32. Morisaki T, Hirota T, Iida S, Marumoto T, Hara T, Nishiyama Y, Kawasuzi M, Hiraoka T, Mimori T, Araki N, Izawa I, Inagaki M, Saya H 2002 WARTS tumor suppressor is phosphorylated by Cdc2/cyclin B at spindle poles during mitosis. FEBS Lett 529:319-324
33. Zhan QM, Antinore MJ, Wang XW, Carrier F, Smith ML, Harris CC, Forance AJ 1999 Association with Cdc2 and inhibition of Cdc2/cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene 18:2892-2900
34. Blank JL, Gerwins P, Elliott EM, Sather S, Johnson GL 1996 Molecular cloning of mitogen-activated protein/ERK kinase kinases (MEKK) 2 and 3. Regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase. J Biol Chem 271:5361-5368
35. Hagemann C, Blank JL 2001 The ups and downs of MEK kinase interactions. Cell Signal 13:863-875
36. Kerr JM, Gordon DF, Woodmansee WW, Sarapura VD, Ridgway EC, Wood WM 2005 Growth arrest of thyrotropic tumors by thyroid hormone is correlated with novel changes in Wnt-10a. Mol Cell Endocrinol 238:57-67
37. Kemppainen RJ, Behrend EN 1998 Dexamethasone rapidly induces a novel ras superfamily member-related gene in AtT-20 cells. J Biol Chem 273:3129-3131
38. Desdouets C, Matesic G, Molina CA, Foulkes NS, Sassone-Corsi P, Brechot C, Sobczak-Thepot J 1995 Cell cycle regulation of cyclin A gene expression by the cyclic AMP-responsive transcription factors CREB and CREM. Mol Cell Biol 15:3301-3309
39. Boulon S, Dantonel JC, Binet V, Vie A, Blanchard JM, Hipskind RA, Philips A 2002 Oct-1 potentiates CREB-driven cyclin D1 promoter activation via a phospho-CREB- and CREB binding protein-independent mechanism. Mol Cell Biol 22:7769-7779
40. Arnould T, Vankoningsloo S, Renard P, Houbion A, Ninane N, Demazy C, Remacle J, Raes M 2002 CREB activation induced by mitochondrial dysfunction is a new signaling pathway that impairs cell proliferation. EMBO J 21:53-63
41. Garcia C, Paez P, Davio C, Soto EF, Pasquini JM 2004 Apotransferrin induces cAMP/CREB pathway and cell cycle exit in immature oligodendroglial cells. J Neurosci Res 78:338-346
42. Musa NL, Ramakrishnan M, Li J, Kartha S, Liu P, Pestell RG, Hershenson MB 1999 Forskolin inhibits cyclin D1 expression in cultured airway smooth-muscle cells. Am J Respir Cell Mol Biol 20:352-358
43. Klemm DJ, Watson PA, Frid MG, Dempsey EC, Schaack J, Colton LA, Nesterova A, Stenmark KR, Reusch JE 2001 cAMP response element-binding protein content is a molecular determinant of smooth muscle cell proliferation and migration. J Biol Chem 276:46132-46141
44. Natsume H, Sasaki S, Kitagawa M, Kashiwabara Y, Matsushita A, Nakano K, Nishiyama K, Nagayama K, Misawa H, Masuda H, Nakamura H 2003 β-Catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone. Biochem Biophys Res Commun 309:408-413
45. Miller LD, Park KS, Guo QM, Alkharouf NW, Malek RL, Lee NH, Liu ET, Cheng SY 2001 Silencing of Wnt signaling and activation of multiple metabolic pathways in response to thyroid hormone-stimulated cell proliferation. Mol Cell Biol 21:6626-6639
46. Smits VA, Medema RH 2001 Checking out the G(2)/M transition. Biochim Biophys Acta 1519:1-12
47. Barrera-Hernandez G, Park KS, Dace A, Zhan Q, Cheng SY 1999 Thyroid hormone-induced cell proliferation in GC cells is mediated by changes in G1 cyclin/cyclin-dependent kinase levels and activity. Endocrinology 140:5267-5274
48. Kastan MB, Zhan Q, el Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace Jr AJ 1992 A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597
49. Tong T, Fan W, Zhao H, Jin S, Fan F, Blanck P, Alomo I, Rajasekaran B, Liu Y, Holbrook NJ, Zhan Q 2001 Involvement of the MAP kinase pathways in induction of GADD45 following UV radiation. Exp Cell Res 269:64-72
50. Zhang X, Sun H, Danila DC, Johnson SR, Zhou Y, Swearingen B, Klibanski A 2002 Loss of expression of GADD45γ, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis. J Clin Endocrinol Metab 87:1262-1267
51. Torres S, Diaz BP, Cabrera JJ, Diaz-Chico JC, Diaz-Chico BN, Lopez-Guerra A 1999 Thyroid hormone regulation of rat hepatocyte proliferation and polyploidization. Am J Physiol 276:G155-G163
52. Pibiri M, Ledda-Columbano GM, Cossu C, Simbula G, Menegazzi M, Shinozuka H, Columbano A 2001 Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3). FASEB J 15:1006-1013
53. Alisi A, Spagnuolo S, Napoletano S, Spaziani A, Leoni S 2004 Thyroid hormones regulate DNA-synthesis and cell-cycle proteins by activation of PKCα and p42/44 MAPK in chick embryo hepatocytes. J Cell Physiol 201:259-265
54. Raff MC, Durand B, Gao FB 1998 Cell number control and timing in animal development: the oligodendrocyte cell lineage. Int J Dev Biol 42:263-267
55. Tokumoto YM, Tang DG, Raff MC 2001 Two molecularly distinct intracellular pathways to oligodendrocyte differentiation: role of a p53 family protein. EMBO J 20:5261-5268
56. Ballock RT, Zhou X, Mink LM, Chen DH, Mita BC, Stewart MC 2000 Expression of cyclin-dependent kinase inhibitors in epiphyseal chondrocytes induced to terminally differentiate with thyroid hormone. Endocrinology 141:4552-4557
57. Buzzard JJ, Wreford NG, Morrison JR 2003 Thyroid hormone, retinoic acid, and testosterone suppress proliferation and induce markers of differentiation in cultured rat Sertoli cells. Endocrinology 144:3722-3731
58. Holsberger DR, Jirawatnotai S, Kiyokawa H, Cooke PS 2003 Thyroid hormone regulates the cell cycle inhibitor p27Kip1 in postnatal murine Sertoli cells. Endocrinology 144:3732-3738
59. Perez-Juste G, Aranda A 1999 The cyclin-dependent kinase inhibitor p27(Kip1) is involved in thyroid hormone-mediated neuronal differentiation. J Biol Chem 274:5026-5031
60. Stork PJ, Schmitt JM 2002 Crosstalk between cAMP andMAPkinase signaling in the regulation of cell proliferation. Trends Cell Biol 12:258-266
61. McCormick F 1999 Signalling networks that cause cancer. Trends Cell Biol 9:M53-M56
62. Mirza AM, Gysin S, Malek N, Nakayama K, Roberts JM, McMahon M 2004 Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT. Mol Cell Biol 24:10868-10881
63. Tang HY, Lin HY, Zhang S, Davis FB, Davis PJ 2004 Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor. Endocrinology 145:3265-3272
64. Bell WC, Myers RB, Hosein TO, Oelschlager DK, Grizzle WE 2003 The response of extracellular signal-regulated kinase (ERK) to androgen-induced proliferation in the androgen-sensitive prostate cancer cell line, LNCaP. Biotech Histochem 78:11-16
65. Treeck O, Diedrich K, Ortmann O 2003 The activation of an extracellular signal-regulated kinase by oestradiol interferes with the effects of trastuzumab on HER2 signalling in endometrial adenocarcinoma cell lines. Eur J Cancer 39:1302-1309
66. Kairouz R, Parmar J, Lyons RJ, Swarbrick A, Musgrove EA, Daly RJ 2005 Hormonal regulation of the Grb14 signal modulator and its role in cell cycle progression of MCF-7 human breast cancer cells. J Cell Physiol 203:85-93
67. Zhu X, Li H, Liu JP, Funder JW 1999 Androgen stimulates mitogen-activated protein kinase in human breast cancer cells. Mol Cell Endocrinol 152:199-206
68. Jiang W, Yang JH, Wang SH, Pan CS, Qi YF, Zhao J, Tang CS 2004 Effects of adrenomedullin on aldosterone-induced cell proliferation in rat cardiac fibroblasts. Biochim Biophys Acta 1690:265-275
69. Fernandes D, Guida E, Koutsoubos V, Harris T, Vadiveloo P, Wilson JW, Stewart AG 1999 Glucocorticoids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracellular-regulated kinases in human cultured airway smooth muscle. Am J Respir Cell Mol Biol 21:77-88
70. Yen A, Roberson MS, Varvayanis S, Lee AT 1998 Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res 58:3163-3172
71. Qui MS, Green SH 1992 PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity. Neuron 9:705-717
72. Frodin M, Peraldi P, Van Obberghen E 1994 Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. J Biol Chem 269:6207-6214
73. Bousquet C, Puente E, Buscail L, Vaysse N, Susini C 2001 Antiproliferative effect of somatostatin and analogs. Chemotherapy 47(Suppl 2):30-39
74. Comi RJ, Gesundheit N, Murray L, Gorden P, Weintraub BD 1987 Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue. N Engl J Med 317:12-17
75. Samuels MH, Ridgway EC 1995 Glycoprotein-secreting pituitary adenomas. Baillieres Clin Endocrinol Metab 9:337-358
76. Brogan MD, Behrend EN, Kemppainen RJ 2001 Regulation of Dexras 1 expression by endogenous steroids. Neuroendocrinology 74:244-250